Dr. Daniel B. Friedman, MD

Dr. Friedman practices at Presbyterian Santa Fe Medical Center in Santa Fe, New Mexico, part of Presbyterian Healthcare Services.

Dr. Friedman's NPI, 1992899363, was assigned on October 3, 2006. Dr. Friedman graduated from Duke University School Of Medicine in 1985. Dr. Friedman holds New Mexico license 94248.

Dr. Friedman's primary practice is Presbyterian Santa Fe Medical Center, at 4801 Beckner Road, Santa Fe, NM 87507 in Santa Fe County. The practice phone is (505) 772-6216.

Dr. Friedman's primary practice is Presbyterian Santa Fe Medical Center in Santa Fe, New Mexico, part of Presbyterian Healthcare Services. Dr. Friedman is also affiliated with CHRISTUS St. Vincent Regional Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Friedman to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Friedman is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Friedman's licenses on file in 3 states: New Mexico, Texas and North Carolina.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, endocarditis, heart blockage and heart failure among the conditions Dr. Friedman treats.

CMS data shows 4,594 Medicare services from Dr. Friedman across 11 procedure codes in 2024, for 3,437 Medicare patients. Medicare paid $61,368 for them.

CMS counts 3,437 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 1,320 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 61, with 54% women.

In 2024, Dr. Friedman wrote 4,557 Medicare Part D claims for 734 patients. 84% of them were for generic drugs. CMS names the drug for 4,352 of them, across 41 drugs with 11 or more claims each, at $724,288 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Friedman for performance year 2024, reported as part of a group. Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Friedman as offering telehealth.

Dmand AI links 95 papers to Dr. Friedman, published from 2009 to 2021. 2018 was the busiest year, with 15. The most frequent topics are Epilepsy, Death, Sudden and Seizures. Dr. Friedman has published most often in Neurology. Dr. Friedman's most frequent co-authors are Orrin Devinsky, MD, Patricia Cristine Dugan, MD and Lisa M. Bateman, MD.

CMS Open Payments shows 53 general payments to Dr. Friedman from 11 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 70% of the total. Medtronic, Inc. paid the most, $1,674.

Dmand AI lists 1 award for Dr. Friedman.

Dr. Friedman graduated from Duke University School Of Medicine in 1985. Dr. Friedman is a member of ACC.

Dr. Friedman is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.